Showing results (151-160 of 1,227) with videos related to

Sort By:
Pageof 123
Cancer Treatment and Research Communications|October 4, 2025
Photodynamic therapy with zinc phthalocyanine enhances cisplatin sensitivity of human muscle-invasive bladder cancer cells by downregulation of PI3K/AKT/mTOR signaling pathwayFateme Mohammadnejad, Neda Rajabi, Mohammad Amin Doustvandi, et al.
Cancer Treatment and Research Communications|September 16, 2021
Granulocyte-colony stimulating factor-associated aortitis in cancer: A systematic literature reviewHideko Hoshina, Hiroyuki Takei
Cancer Treatment and Research Communications|August 23, 2021
PAX5 haploinsufficiency induced CD8+ T cells dysfunction or exhaustion by high expression of immune inhibitory-related moleculesMi Liang, Duanhao Gong, Lei Wang, et al.
Cancer Treatment and Research Communications|September 18, 2025
Furmonertinib rechallenge for first-line third-generation EGFR TKI-resistant EGFR-mutant NSCLC: A retrospective propensity score-matched cohort studyJiaqi Zhao, Maolin Liu, Siqing Liu, et al.
Cancer Treatment and Research Communications|September 19, 2025
A bibliometric analysis on KRAS, a targeted marker for blockbuster clinical drugsZongzhen Guo, Shiqing Zhao, Yanfei Sun, et al.
Cancer Treatment and Research Communications|September 8, 2025
Clinical and molecular characteristics of 42 Danish patients with metastatic ALK fusion-positive lung cancer treated with first-line alectinib: A nationwide studyMaiken Parm Ulhøi, Emma Roger Andersen, Christoffer Trier Maansson, et al.
Cancer Treatment and Research Communications|September 11, 2025
Prognostic value of FBXW7 tumor suppressor gene expression and mutations in patients with colorectal cancer: A meta-analysisMohammad Rahmanian, Iman Elahi Vahed, Mohammad Shirali, et al.
Cancer Treatment and Research Communications|August 14, 2025
The effect of postoperative chemotherapy on blood glucose and prognosis in patients with advanced ovarian cancerTing Du, Xueli Zha, Yawen Zhang, et al.
Cancer Treatment and Research Communications|August 14, 2025
Management of immune-related adverse events under PD-1/PD-L1 inhibitors: Insights from a Moroccan real-world experienceInès Cherradi, Mohamed Ichou, Mohammed Squalli Houssaini, et al.
Pageof 123